2Selective neuronal PTEN deletion:can we take the brakes off of growth without losing control?1201-1203
3TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration1204-1207
4Tamoxifen:an FDA approved drug with neuroprotective effects for spinal cord injur y recover y1208-1211
6Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis:how far are we from a clinical treatment?1216-1219
7Volume transmission and receptor-receptor interactions in heteroreceptor complexes:understanding the role of new concepts for brain communication1220-1223
12Skeletal muscle conditioning may be an effective rehabilitation intervention preceding functional electrical stimulation cycling1232-1233
15Beyond reproduction:the role of progesterone in neuropathic pain after spinal cord injur y1238-1240
17Melanopsin expression is an indicator of the well-being of melanopsin-expressing retinal ganglion cells but not of their viability1243-1244
18Calcium channel inhibition-mediated axonal stabilization improves axonal regeneration after optic nerve crush1245-1246
19A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injur y:a molecular dynamics simulation study1247-1253
20Glucose metabolism and neurogenesis in the gerbil hippocampus after transient forebrain ischemia1254-1259
